Showing results (141-150 of 166) with videos related to
Sort By:
Pageof 17
International Journal of Hematology|September 29, 2022
Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II studyNoriko Fukuhara, Dai Maruyama, Kiyohiko Hatake, et al.Cancer Science|June 6, 2017
Phase II study of intrabone single unit cord blood transplantation for hematological malignanciesMakoto Murata, Yoshinobu Maeda, Masayoshi Masuko, et al.Cancer Science|July 24, 2026
Real-World Safety and Efficacy of Pola-R-CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 PatientsTakahiro Kumode, Hitomi Sawa, Kohta Miyawaki, et al.International Journal of Hematology|December 3, 2025
Preliminary analysis of a multicenter study of Pola-R-CHP in untreated Japanese patients with DLBCL (POLASTAR)Atsushi Satake, Yasuhiro Nagate, Kohta Miyawaki, et al.Cancer Science|March 31, 2018
Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapyMotoko Yamaguchi, Ritsuro Suzuki, Seok Jin Kim, et al.Japanese Journal of Clinical Oncology|November 5, 2021
Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapyKazuhito Yamamoto, Atsushi Shinagawa, Courtney D DiNardo, et al.International Journal of Hematology|December 1, 2016
Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in JapanMichinori Ogura, Kenichi Ishizawa, Dai Maruyama, et al.Journal of Clinical and Experimental Hematopathology : JCEH|July 31, 2024
Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin's lymphomaTatsuo Oyake, Takahiro Maeta, Takenori Takahata, et al.Cancer Science|July 22, 2024
Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305)Shigeru Kusumoto, Wataru Munakata, Ryunosuke Machida, et al.Journal of Clinical and Experimental Hematopathology : JCEH|June 28, 2023
Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphomaEiju Negoro, Takahiro Yamauchi, Noriko Fukuhara, et al.Pageof 17